CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Not yet recruiting	Phase 4	2025-01-08		NCT06763666

29 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Guangdong Medical University	27
Central People's Hospital of Zhanjiang	7
Dongguan People's Hospital	32
First Affiliated Hospital of Guangxi Medical University	96
First People's Hospital of Foshan	44
Foresea Life Insurance Guangzhou General Hospital	1
Guangdong Second Provincial General Hospital	22
Guangzhou First People's Hospital	32
Guangzhou General Hospital of Guangzhou Military Command	5
Guangzhou No.12 People's Hospital	4
Guangzhou Panyu Central Hospital	5
Guilin Medical University, China	9
Hainan General Hospital	12
Huizhou Municipal Central Hospital	21
Jiangmen Central Hospital	27
LiuZhou People's Hospital	15
Maoming People's Hospital	6
Nanfang Hospital, Southern Medical University	248
Peking University Shenzhen Hospital	48
Second Affiliated Hospital of Guangzhou Medical University	70
Shantou Central Hospital	13
Shenzhen Hospital of Southern Medical University	16
Shenzhen Second People's Hospital	31
Southern Medical University, China	37
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Hematology,Nanfang Hospital, Southern Medical University	Guangzhou	China	3

Clinical trials